Top 3 Solana Rivals On The Verge Of Turning $10 To $1000

INTRODUCTION
Following the FTX implosion, SOL tumbled to $8 giving savvy investors a chance to buy the heavily discounted crypto gem which recently topped $210 before correcting to $162. At the time of writing, Solana had recovered to $180. If investors desire such gains, they may want to get into the top 3 Solana rivals that could quickly flip a $10 portfolio into $1,000 including Dogecoin (DOGE), Injective (INJ), and Bitcoin Cash (BCH).


1. Dogecoin (DOGE)
The meme coin Dogecoin has impressively bounced back alongside a broader rally in the cryptocurrency sector, indicating a resurgence of investor trust in digital assets. Bitcoin has soared past the $66,000 mark, while Ethereum has climbed above $35,000, demonstrating widespread market enthusiasm.

After more than a year of stable trading, Dogecoin broke through the $0.1 barrier, reaching peaks above $0.2. Following this, the price encountered a bearish phase, confining it to a tight zone around $0.15. Nevertheless, the current positive momentum in the market suggests Dogecoin is on the verge of a significant upswing.

2. Injective (INJ)
Injective (INJ) is making waves in the finance world with its pioneering, transparent, and interoperable first-layer blockchain. This platform is leading the charge in fostering a new wave of DeFi applications. Its offerings span decentralized exchanges for spot and derivatives trading, markets for predictions, and lending protocols.

3. Bitcoin Cash (BCH)
The rally in Q4 prepared Bitcoin Cash for a bigger rally in Q1 which blasted the coin to new yearly highs at $530. However, the bullish theory took a temporary dive at the beginning of March as investors pocketed early profits.

BCH found relief from this temporary dive at $350 although a candle wick extended to $340 as shown on the four-hour chart.